Article > NICE final "no" for BM-S' Orencia in RA
Links shared publicly online about this topic.
- 47total visits
Article > NICE final "no" for BM-S' Orencia in RA
Article > NICE final "no" for BM-S' Orencia in RA
View full resource at pharmatimes.com
Tags: Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Drug, Orencia, Bristol-Myers Squibb
Most Recently Shared on August 25, 2011 at 12:30 pm By:
Bristol-Myers Squibb's RA drug Orencia got the final thumbs down from U.K. cost-effectiveness agency. http://t.co/JFs85MD $BMY
Advertisement
